Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.
Arthritis & rheumatology (Hoboken, N.J.)·2018
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
A Phase 1b/2 trial of mapatumumab in patients with relapsed/refractory non-Hodgkin's lymphoma.
British journal of cancer·2010
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Experiences of the dying.
The Journal of practical nursing·2012
Transitioning the practical nursing student into practice: outcomes of a geriatric initiative.
The Journal of practical nursing·2012
Simulation in Kansas practical nursing programs.
The Journal of practical nursing·2012
Simulation in Kansas practical nursing programs.
The Journal of practical nursing·2012
Predicting NCLEX-PN success with the HESI Exit Exam.
The Journal of practical nursing·2011
Enhancing students' clinical experience: simple ideas that work.
The Journal of practical nursing·2010
It's More than Warm Communication: A Pre-Registered Analysis of Patient's Compassion Priorities.
Journal of patient experience·2026
Effects of exposure to Active Minds' Send Silence Packing exhibit on college students' mental health help-seeking intentions.
Journal of American college health : J of ACH·2026
Community perceptions of chemsex practices in Türkiye: a cross-sectional online survey.
BMC public health·2026
Exploring neural underpinning of Christian faith: How far can we go?
Brain and cognition·2026
Cannabis Use Patterns and the Strength of Belief: Challenging the Religious-Atheist Division.
Substance use & addiction journal·2026